F16.90
Hallucinogen use, unspecified, uncomplicated
Clinical Classification Guidelines
Medical Intelligence & Overview
Hallucinogen use, unspecified, uncomplicated (ICD-10 Code: F16.90), refers to the consumption of substances that cause altered perceptions, sensations, and thought processes without resulting in complications or additional medical issues at the time of diagnosis. These substances, often used recreationally, include various drugs that induce hallucinations and perceptual distortions. This condition indicates that the individual has recently used hallucinogens but has not experienced immediate physical or psychological complications, making it a key focus for ongoing health monitoring and education.
Causes & Symptoms
Clinical Causes: Use of recreational hallucinogenic substances such as LSD, psilocybin mushrooms, DMT, or mescaline. Possession or access to psychoactive substances that induce hallucinations. Social environments that promote or encourage the use of hallucinogens. Psychological factors like curiosity, peer influence, or mental health conditions that predispose to drug experimentation. Lack of awareness or understanding of the potential effects and risks of hallucinogenic substances.
Key Symptoms: Visual or auditory hallucinations where the individual perceives sights or sounds that are not present. Altered perceptions of time and space, leading to feelings of time dilation or distorted spatial awareness. Changes in mood, such as euphoria, anxiety, or paranoia. Sensory enhancement or intensification, making music, colors, or tactile sensations seem more vivid. Dizziness, nausea, or physical discomfort in some cases. Impaired judgment or coordination, which can increase the risk of accidents. Difficulty concentrating or maintaining focus.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical assessment that considers reported substance use, physical examination, and mental health evaluation. Healthcare providers may perform drug screening tests to confirm recent hallucinogen use. Since the condition is specified as uncomplicated, no immediate physical or mental health issues attributable to the substance use are present at the time of assessment. Thorough documentation of the patient's history and behavioral observations are essential components of the diagnostic process.
Treatment Protocols: Providing a safe environment and reassurance to address anxiety or paranoia. Monitoring the individual until the effects of the substance diminish, which often occurs within several hours. Educating about the potential risks associated with hallucinogenic substances to prevent future use. Referral to mental health or substance abuse counseling if necessary, especially if usage becomes frequent or problematic. Addressing any underlying psychological or social factors through therapy or support groups.
Clinical Advice & FAQs
Billing Guidance
Is F16.90 a billable ICD-10 code?
Yes, F16.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.90?
Clinical documentation must specify the nature of Hallucinogen use, unspecified, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference